ny_banner

Products

Iron Dextran Solution 20% High Content Of Dextran

Short Description:

Iron Dextran Solution is an injectable iron supplement used to treat iron deficiency anemia in animals. It is a sterile, colorless to brownish-black solution containing ferric hydroxide in complex with dextran. The product is intended for intramuscular or slow intravenous administration and is available in various concentrations and volumes to meet the needs of different animal species and sizes. With its high bioavailability and safety profile, Iron Dextran Solution is a trusted choice for veterinarians seeking to improve the health and wellbeing of their patients.


Product Detail

Product Tags

Description

Name: Iron Dextran solution 20%
Other name: Iron dextran complex, ferric dextranum, ferric dextran, iron complex
CAS NO 9004-66-4
Quality Standard I. CVP  II.USP
Molecular formula (C6H10O5)n·[Fe(OH)3]m
Description Dark brown colloidal crystalloid solution, phenol in flavour.
Effect Anti-anemia medicine, which can be used in the iron-deficiency anemia of newborn piggies and other animals.
Characteristic With highest ferric content comparing to the similar products in the world. It is absorbable quickly and safely, good effect.
Assay 200mgFe/ml in solution form.
Handling & Storage To maintain stable high quality of product, store it with room temperature; keep away from sunshine & lighting.
Package Plastic drums of 30L,50L,200L

Analysis And Discussion

1. By injecting 1 ml of Futieli to piglets at the age of 3 days, they gained a net weight of 21.10% at the age of 60 days. This technology is easy to use, control, and offers an accurate dose, leading to weight gain and good benefits.

2. Within 20 days, there was no significant difference in the average weight and hemoglobin content of piglets aged 3 to 19 days who did not receive iron supplementation. However, the experimental group exhibited a significant difference in body weight and hemoglobin content compared to the control group, indicating that Futieli can improve the regression relationship between weight gain and hemoglobin traits in piglets.

3. Within the first 10 days of birth, piglets in the experimental and control groups had no significant difference in body weight. However, there was a notable variance in hemoglobin content, with Futieli demonstrating the capability to stabilize the hemoglobin levels of piglets within 10 days post-injection. This stabilization provides a solid foundation for future weight gain and development.

days

group

weight

gained

compare

numerical value

compare(g/100ml)

newborn

experimental

1.26

reference

1.25

3

experimental

1.58

0.23

-0.01(-4.17)

8.11

+0.04

reference

1.50

0.24

8.07

10

experimental

2.74

1.49

+0.16(12.12)

8.76

+2.28

reference

2.58

1.32

6.48

20

experimental

4.85

3.59

+0.59(19.70)

10.47

+2.53

reference

4.25

3.00

7.94

60

experimental

15.77

14.51

+2.53(21.10)

12.79

+1.74

reference

13.23

11.98

11.98


  • Previous:
  • Next:

  • Write your message here and send it to us